We reviewed published data on the frequency of underlying disorders in schoolchildren with microscopic or gross isolated haematuria (IH), and evaluated management strategies. We found five reports of microscopic IH in screened asymptomatic schoolchildren, three reports of microscopic IH detected by case-finding, and five surveys of kidney biopsies in referred children with microscopic and gross IH. We listed the reported underlying disorders, and estimated the benefit from their early detection and treatment. Most children with microscopic IH, whether detected by screening or case-finding, had no significant underlying disease. Some had disorders that may benefit from early treatment (membranoproliferative glomerulonephritis, obstructive uropathy, urolithiasis), or counselling (hereditary nephropathy, renal cystic disease). The combined prevalence of these five diseases was 0-7.2% in children with microscopic IH detected by screening, and 3.3%-13.6% in those with microscopic IH detected by case-finding. The combined prevalence of membranoproliferative glomerulonephritis and hereditary nephropathy among kidney biopsies was 11.6%-31.6% in children with microscopic IH, and 3.6%-42.1% in children with gross IH. Variable management strategies for schoolchildren with IH result from uncertainty about the frequency of underlying disorders and the efficacy of their early treatment. With no evidence that detecting IH leads to prevention of renal function impairment, screening for IH in symptomless schoolchildren is not warranted. Once detected, however, IH justifies further investigation.
Introduction
Symptomless haematuria without growth failure, hypertension, oedema, proteinuria, urinary casts or renal impairment ('isolated haematuria', IH) is a frequent abnormality on urinary screening of schoolchildren 1 and the second most common reason for referral to paediatric nephrology clinics in the USA. 2 Its point prevalence among screened schoolchildren is 0.25-1 %, [3] [4] [5] [6] varying according to the criteria used for its definition: five or more red blood cells per high-power field (RBC/HPF) are more frequently seen than > 2 0 RBC/HPF, and a single occurrence of haematuria is more common than a recurrent finding. 1 The prevalence of IH has been reported to increase with age by some authors, 1 ' 3 ' 5 but not others. 4 Its cumulative incidence rises with repeated examinations, so that by 12 years of age, 3.2% of girls and 1.4% of boys have > 5 RBC/HPF in two urine specimens on at least one of five consecutive annual examinations. 1 The difficulties in determining the frequency of IH are further compounded by the relatively low accuracy of the HPF method, because of differences in density and volume of the centrifuged specimen, in the volume of the discarded supernatant fluid, in the duration of centrifugation and in the width of the sediment layered on the slide. 7 There is general agreement that a finding of gross haematuria or a recurrent finding of microhaematuria in an otherwise healthy child mandates a family history, a search for precipitating factors (infection, medications, bleeding tendency), urinalysis (protein, casts), a baseline serum creatinine measurement and urinalyses of other family members. However, opinion is divided regarding the need for, and extent of, additional tests. Some authors advocate no further examinations unless the child develops systemic symptoms or signs, or a decline in renal function. 1 Others advocate an evaluation restricted to urine culture only, 8 urine culture and urinary calcium/ creatinine ratio, 9 renal sonography alone, 10 or renal sonography supplemented by urinary calcium/ creatinine ratio and a sickle-cell preparation in a Black child, 11 or a more extended evaluation consisting of renal sonography, urinary calcium/creatinine ratio, a sickle-cell preparation in a Black child, serum complement levels (C 3 and C 4 ), antinuclear activity (ANA) and anti-DNA. 12 20 with a subsequently poorer prognosis. 21 ' 22 These uncertainties may by due to differences in studied populations: some recommendations are based on findings in subjects with microscopic IH detected by screening, while others arise from observations on either subjects with microscopic IH detected by case-finding or on kidney biopsies of children referred for gross IH.
The objective of this study was to explore these uncertainties. We compared the reported prevalence of disease in children with microscopic IH detected by screening and case-finding, as well as that in referred children with microscopic and gross IH. An attempt is made to determine whether (i) the conclusions based on observations on schoolchildren with microscopic IH detected by screening may be generalized over those presenting in clinical practice with symptomless microscopic or gross IH, and (ii) whether the present state of our knowledge permits a reduction of the confusingly large number of recommendations for the management of IH.
Methods
We searched the literature (Medline 1981-1995) for reports on haematuria in childhood, and their reference sections were examined for relevant previous publications. We excluded reports that did not distinguish between adults and children, 23 (Table 2) , one study of microscopic or gross IH in referred schoolchildren 20 (Table 3) , and five surveys of kidney biopsies performed for microscopic or gross IH in referred schoolchildren 13 ' 36 "
39
( Table 4 ). The main weakness of these studies was the absence of clear inclusion criteria. The only feature common to all subjects was a finding of microscopic or gross IH. None of the prospective screening studies (Table 1) specified the patterns of referral for investigations. The number of subjects with IH detected by screening who were referred for further examinations was given only in the study by Dodge et al} The retrospective nature of the reviews of referred children with IH (Tables 2 and 3 ) and surveys of kidney biopsies ( nephropathy) and non-specific histological findings (e.g. diffuse mesangial proliferation) that may be associated with a variety of diseases. Although imperfect, these studies were the only available sources of data on the significance of IH in schoolchildren. We listed all reported underlying disorders, except Henoch-Schoenlein purpura, which mandates additional diagnostic features, such as rash and abdominal pain, and therefore cannot be included in the category of symptomless haematuria. The results are presented as proportions (percentages). The numerators are the number of patients diagnosed as having a defined clinical disorder or renal histological finding, and the denominators are the total number of children with IH investigated in each of the clinical studies or the total number of reviewed kidney biopsies. The recent literature was also searched for data on the prognosis and efficacy of treatment of the disorders that may present with IH.
Results

Prevalence of renal disease among schoolchildren with symptomless isolated haematuria
Symptomless isolated microhaematuria in screened children (Table 1) The most commonly reported biopsy-proven glomerular disorders were IgA and hereditary nephropathy. IgA nephropathy was found in 2.4% 4 Table 1 ).
The most common non-glomerular finding among screened children with microscopic IH was asymptomatic urinary tract infection (UTI). UTI was detected in 4.8% 6 to 6.0% 4 of the patients. Uncommon non-glomerular findings were: ureteropelvic junction obstruction, vesicoureteral reflux/obstruction and renal cystic disease; their prevalence among schoolchildren with IH, however, exceeded that detected by sonography in a non-selected population of schoolchildren in Taiwan. 40 Symptomless isolated microhaematuria in referred children (Table 2) The most common biopsy-proven glomerular disorder in referred children with microscopic IH was focal or diffuse mesangial proliferative glomerulonephritis and hereditary nephropathy. Hereditary nephropathy was found in 8.3% 18 Symptomless isolated microscopic or gross haematuria in referred children (Table 3 ).
Turi ef a/. 20 reported the follow-up of 106 children with microscopic IH and 235 children with gross 'Cases with this disorder were excluded from the study.
IH. Focal and diffuse proliferative glomerulonephritis were the most common glomerular lesions (6.5%) followed by hereditary (4.1%) and IgA (0.9%) nephropathy. MPGN was found in 0.9% of all patients. Children with infections and obstructive urological lesions were excluded from the study. Therefore, the only non-glomerular lesions in their series were hypercalciuria (19.9%) and urolithiasis (14.4%). The authors did not report whether there were any differences in prevalence of underlying disorders among children with microscopic and gross IH.
Surveys of kidney biopsies in referred children with symptomless isolated microhaematuria or gross haematuria (Table 4)
There was a marked difference in prevalence of glomerular lesions among published surveys of kidney biopsies performed for microscopic or gross IH ( 
Prognosis and treatment of disorders that may present with symptomless isolated haematuria
The disorders that may present with IH, whether microscopic or gross, can be classified into three categories according to prognosis and treatability. 52 We found no studies on the prognosis of focal or diffuse mesangial proliferation in children with IH. Adults with this histological finding, particularly those presenting with haematuria only, have a good prognosis 53 ' 54 and require no treatment beyond follow-up. The second category includes diseases with uncertain prognosis, that require no treatment as long as the patient is asymptomatic. Schoolchildren with vesicoureteral reflux require no long-term prophylactic antimicrobial treatment in the absence of symptomatic urinary tract infections. 55 Although hypercalciuria is a risk indicator for urolithiasis, its inconsistency during follow-up has precluded any evaluation of the efficacy of preventive treatment. At present, most authorities recommend expectant follow-up. 56 " 58 There is evidence that adults with nephrotic syndrome due to idiopathic MN respond 59 However, of ten controlled trials, only five produced results supporting therapy (see reference 60 for review). Since untreated patients with idiopathic MN maintain a normal renal function for prolonged periods of time, at present treatment with glucocorticoids and immunosuppression is considered only in those with declining renal function. 60 Similarly to focal/diffuse mesangial proliferation, FSGS is a nonspecific manifestation of a variety of disorders, e.g. reflux nephropathy and obesity. 61 We know of no studies on the prognosis of FSGS in children presenting with IH. When associated with nephrotic syndrome, FSGS is often characterized by a progressive loss of renal function; 62 " 64 when associated with mild proteinuria only, FSGS has a better prognosis 65 and is rarely treated. 66 The third category includes disorders that may benefit from treatment (tubulointerstitial nephritis, urolithiasis, ureteropelvic junction obstruction, MPGN) or counselling (hereditary nephropathies and renal cystic disease). Treatment of symptomless tubulointerstitial nephritis consists of the elimination of the underlying cause, 9 i.e. hypersensitivity reaction to medication. Other possible underlying causes such as systemic lupus erythematosus or systemic infections are unlikely to present with symptomless IH. Treatment of urolithiasis consists of removal of the stones and correction of anatomic or metabolic predisposing factors. 67 Pelvic dilatation due to ureteropelvic junction obstruction with a normal dynamic renal scan in an asymptomatic child does not warrant treatment, while severe forms of hydronephrosis may have to be treated surgically. 52 Earlier studies failed to detect any effect of treatment on the outcome of children with MPGN. 68 However, more recent retrospective uncontrolled studies, 69 ' 70 and a prospective randomized trial 71 have indicated that corticosteroid treatment may forestall renal insufficiency, despite a relatively high incidence of complications. 71 The favourable effect of treatment in these latter studies was attributed to early intervention within 1 year of the onset of clinically apparent disease. 69 However, a recent study has questioned the efficacy of corticosteroid treatment in nonnephrotic children with membranoproliferative glomerulonephritis. 72 There is no treatment for renal cystic disease and for the hereditary nephropathies. However, their detection may be important for genetic counselling. Most patients with the hereditary nephropathies show diffuse or focal thinning of the glomerular basement membrane on renal biopsy. 73 76 Follow-up studies have reported either no deterioration in renal function despite persistent microhaematuria, 19 ' 30 ' 77 or a progression of the thin glomerular basement membrane to the 'basket weave' pattern of Alport's syndrome. 78 Prognosis is therefore uncertain, and counselling is based on the course of the disease in other family members, 79 rather than on the histological appearance of the kidney.
Discussion
The main finding of this review is the paucity of available data on the clinical significance of childhood IH. We found only one longitudinal study of children with microscopic IH, 6 and no longitudinal studies of cohorts with gross IH only. A second source of uncertainty is the unknown natural history of presymptomatic MPGN, urolithiasis and ureteropelvic junction obstruction. Consequently, we do not know whether their treatment in the presymptomatic stage is more effective than that in symptomatic children and whether the benefit of their detection justifies the inconvenience and cost of the investigations. Despite their limitations, we believe the reviewed studies warrant several tentative conclusions. First, screened and referred children with microscopic and gross IH had similar underlying glomerular and non-glomerular disorders. Hereditary nephropathy appeared to be more frequent among referred (Tables 2-4) than among screened (Table 1 ) children with IH. IgA nephropathy was consistently more frequent among referred children with gross IH than among those with microscopic IH (Table 4 ). There were no consistent differences in prevalence of the remaining glomerular lesions between children with microscopic and gross IH (Tables 1-4 ). The prevalence of hypercalciuria and urolithiasis in the series reported by Turi et a/., 20 which included children with both microscopic and gross IH ( Table 3 ), exceeded that among children with microscopic IH (Table 2) . It is possible therefore, that the prevalence of nonglomerular lesions among children with microscopic IH is not generalizable to children with gross IH.
Secondly, interstitial nephritis, systemic lupus and renal cystic disease have been only rarely reported in children with microscopic HT and it is therefore, doubtful whether they should be considered in the differential diagnosis. Lastly, hypercalciuria and urinary tract infections do not appear to be more frequent among children with microscopic IH than in the general population of schoolchildren. There is an undisputed association of hypercalciuria with gross haematuria. 20 The justification for a recommendation of medical examinations for asymptomatic persons is the detection of diseases, in which treatment has been shown to be more effective during the presymptomatic stage than after onset of symptoms or signs. 86 This premise precludes a focussed search for microscopic IH among asymptomatic children. Once detected, however, the extent of evaluation of IH depends on its value in terms of relief of parental anxiety, reduced need for follow-up and on the expected benefit from the management of the detected disorder. Parental anxiety will be probably relieved by the wide discrepancy between the high prevalence of microscopic IH among schoolchildren 1 " 5 relative to that of renal failure, and by the conclusions of the follow-up study by Hisano et al. 6 We do not believe that the results of diagnostic examinations, whether positive or negative, will obviate the need for follow-up. Therefore, the investigation of IH in a symptomless child should be guided by the expected benefit from treatment or counselling for the detected disorder, rather than by an unyielding quest for diseases, for which treatment is either unavailable or not indicated in asymptomatic children. A focus on treatable disease argues against determinations of calcium excretion and serum immunoglobulins, voiding cystography and urine cultures, and suggests that interstitial nephritis and postinfectious glomerulonephritis should be looked for by a careful history, but not by anti-streptolysin titre or throat cultures. The rarity of lupus nephritis presenting with IH does not justify testing for ANA or LE preparations. The extent of the diagnostic evaluation of IH depends therefore, on the expected benefit from treatment or counselling in presymptomatic patients with hereditary nephropathy, MPGN, urolithiasis, obstructive uropathy and renal cystic disease.
An assumption that early treatment or counselling is effective in none of these disorders would justify a strategy of expectant management by periodic examination and determinations of urinary protein and serum creatinine. If erroneous, this assumption may delay the detection and treatment of up to five cases of hereditary nephropathy, seven cases of MPGN, one case of urolithiasis, five cases of obstructive uropathy and one case of renal cystic disease among every 200 schoolchildren with IH detected by screening (Table 1) or up to 23 cases of hereditary nephropathy, 10 cases of obstructive uropathy and 30 cases of urolithiasis among every 200 schoolchildren with IH detected by case-finding (Table 2 ).
An assumed (but so far not proven) benefit from early treatment or counselling in patients with obstructive uropathy, renal cystic disease and urolithiasis would justify a sonography of the entire urinary tract. Lastly, an assumed, but similarly not proven, benefit from counselling for hereditary nephropathy or treatment of presymptomatic MPGN would justify (i) a thorough family history for deafness and renal disease and urinalysis of other family members, and (ii) testing for serum complement levels, a repeated testing of those with a low level, and renal biopsy in those with persistently low serum complement levels. Using this strategy, Itaka ef a/. 87 found serum C 3 level < 3 0 m g / d l in five of 121 children with urinary abnormalities detected in the Japanese screening program. Of these five children, four underwent kidney biopsy and were found to have MPGN. One of these four had IH, while the remaining three presented with proteinuria and microhaematuria. 87 The sensitivity of a low serum C 3 ( < 6 0 % of normal) for MPGN in children is 62%. 88 Therefore, this strategy is expected to detect only four of the seven cases of MPGN among 200 children with IH. Does early detection of the three remaining cases of normo-complementemic MPGN justify a kidney biopsy in 200 or more children with IH? Treatment of children with MPGN has been reported to reduce the progression to renal failure from 42% to 30% during 10 years follow-up. 70 In other words, treatment of 100 children with MPGN prevented 12 cases of renal failure. The detection of 100 cases of MPGN, with subsequent prevention of 12 cases of terminal renal failure, would necessitate sonography and kidney biopsies in at least 6700 children with IH at a possible cost of two biopsy-related deaths and 67 cases of serious morbidity. 89 This trade-off is unacceptable, even if the risk of kidney biopsy in healthy children is lower than that reported in the entire patient population. As long as the prevalence of the disorders associated with IH and the benefit of their early treatment in schoolchildren remain uncertain, either of the discussed three strategies (no tests, sonography alone or sonography and serum C 3 levels) should be accepted as legitimate. These conclusions are valid for microscopic IH, whether detected by screening or case-finding, but not for gross IH. The uncertainties identified in this review may be resolved by additional observational studies of children with IH, particularly with gross IH, and by their follow-up. Until the results of such prospective studies become available, the choice between the three evaluation strategies should be discussed with the patient or the patient's guardian, after emphasizing the limitations of our present knowledge.
